Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431

Read full text Summarise with VIRAT
Authors: Katrina Winsnes, Julie Ann Bradley, Zhengya Gao, Abha A. Gupta, David H. Rothstein, Archana Shenoy, Rajkumar Venkatramani, Wei Xue, Carola Arndt
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Rhabdomyosarcoma is the most common soft tissue sarcoma in pediatrics and infants are reported to have inferior outcomes. ARST1431 recommended delayed primary excision (DPE) while discouraging radiation (RT) deviations. This analysis compared outcomes among very young and older patients in this study. PROCEDURES: Demographic and tumor characteristics were summarized using frequencies and percentages. Local failure (LF) frequency was summarized by age group, RT, and DPE status. Event-free survival (EFS) and overall survival (OS) were estimated using the Kaplan-Meier method and compared between age groups using the log-rank test. RESULTS: Of 296 patients, 48 (16.2%) were

Fields of Study & Subjects

Sarcoma Diagnosis and Treatment Acute Lymphoblastic Leukemia research Childhood Cancer Survivors' Quality of Life

Publication details

Journal / source
Pediatric Blood & Cancer
Volume
73
Issue
6
Pages
e70293–e70293
Publication date
31 March 2026
Language
EN